相关实验视频
Updated: Jan 11, 2026

04:23
Application of Hemostatic Devices in Laparoscopic Hepatectomy
Published on: April 19, 2022
2.7K
被动,活跃或两者兼而有之 - - 手术师在现实世界中选择哪些血静止剂,我们是否应该重新考虑这一点?
Kristen Knapp1, Isabella G Armento1, Rhea Parreno2
1Department of Surgery, Cooper University Hospital, Camden, NJ, USA.
Medical devices (Auckland, N.Z.)
|November 10, 2025
概括
这项研究比较了主动,被动和联合局部止血剂. 虽然组合组的血液损失较高,但在各组估计的血液损失中没有发现显著差异.
科学领域:
- 手术创新 在外科创新.
- 临床结果研究研究
- 血静管理 血静管理
背景情况:
- 局部静血剂在手术中至关重要.
- 代理物被分为积极的,被动的或组合的.
- 它们对血液损失和结果的影响需要评估.
研究的目的:
- 评估血液静止剂类型与手术结果之间的关联.
- 为了在不同的静血策略中比较手术内流血和术后并发症.
- 确定最佳的静血剂选择,以改善患者护理.
主要方法:
- 对149名手术患者的回顾性分析.
- 三种血液静止策略的比较:活性,被动和组合剂.
- 估计血液损失 (EBL) 和术后结果的评估.
主要成果:
- 组合组表现出最高的平均EBL (521.3毫升),其次是活跃 (390.7毫升) 和被动 (301.5毫升) 组.
- 两组之间没有观察到调整后平均EBL的统计学上显著差异 (p = 0.309).
- 接受联合药物的患者经历了更长的手术时间,更长的ICU停留时间和更高的死亡率.
结论:
- 数字趋势表明,血液出血增加和复杂的术后疗程与联合静血剂.
- 标准化出血措施和战略性并发症管理可能会改善结果.
- 需要进一步的研究来优化血液静止剂的使用.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
Venous Thrombosis III: Interprofessional Care
271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Hemodialysis I: Introduction
1.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.2K
Peripheral Artery Disease V: Postoperative Nursing Management
360
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
360

